Primary Site >> Pancreatic Cancer
Gene >> SLC6A2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The pancreatic duct mucosal barrier. PMID: 31807 |
Ref: Evaluation of computed tomography in pancreatic cancer. PMID: 7225597 |
Ref: Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. PMID: 6593727 |
Ref: Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell lines. PMID: 2751260 |
Ref: [Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines]. PMID: 1952962 |
Ref: Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line. PMID: 7627976 Ref: Drinking water mutagenicity and leukemia, lymphomas, and cancers of the liver, pancreas, and soft tissue. PMID: 7677425 |
Ref: [Chemotherapy for adenocarcinoma of the pancreas]. PMID: 9276871 |
Ref: Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. PMID: 9665483 |
Ref: Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. PMID: 10601579 Ref: Is the new classification of neuroendocrine pancreatic tumors of clinical help? PMID: 11038199 Ref: Neurotensinomas PMID: 25905306 |
Ref: Simultaneous analysis of quality of life and survival data. PMID: 11923992 Ref: Treatment with 5-fluorouracil enhances radiosensitivity of the human pancreatic cancer cell line MiaPaCa-2. PMID: 12120006 Ref: Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. PMID: 12168845 |
Ref: Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. PMID: 12848590 Ref: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. PMID: 12970142 |
Ref: Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. PMID: 14624668 Ref: [(131)I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-( 2-napthyl)propanamide PMID: 20641809 Ref: Avidin conjugated to tetramethyl-6-carboxyrhodamine-QSY((R))7 PMID: 20641900 |
Ref: Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2. PMID: 15674444 Ref: Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones. PMID: 15822132 |
Ref: Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor. PMID: 16417269 Ref: Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. PMID: 16818649 |
Ref: Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells. PMID: 17426390 Ref: Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. PMID: 18063942 Ref: Regionalization versus competition in complex cancer surgery. PMID: 18634671 |
Ref: An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression. PMID: 18025811 Ref: Growth inhibitory effect of the ternary complex factor Net on human pancreatic carcinoma cell lines. PMID: 18832796 Ref: Laparoscopic enucleation of a nonfunctioning neuroendocrine tumor of the pancreas. PMID: 18972611 |
Ref: Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). PMID: 19115524 Ref: Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene. PMID: 19470726 |
Ref: Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. PMID: 19506898 Ref: Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. PMID: 19933912 Ref: EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer. PMID: 20041350 Ref: Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). PMID: 20139156 Ref: Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. PMID: 20168287 |
Ref: Definitive diagnosis of neuroendocrine tumors using fine-needle aspiration-puncture guided by endoscopic ultrasonography. PMID: 21434714 Ref: Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. PMID: 21622854 Ref: [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy]. PMID: 21656305 Ref: Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. PMID: 21731519 Ref: Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer. PMID: 21843259 Ref: [What's new? The 2010 WHO classification for tumours of the pancreas]. PMID: 21915659 Ref: Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors. PMID: 22009449 Ref: Loss of PTEN expression in neuroendocrine pancreatic tumors. PMID: 22105477 Ref: Conundrums and Caveats in Neuroendocrine Tumors of the Pancreas. PMID: 26837490 |
Ref: Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns. PMID: 22157030 Ref: [Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.] PMID: 22294240 Ref: Unusual, metastatic, or neuroendocrine tumor of the pancreas: a diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry. PMID: 22421714 Ref: [Multidisciplinary therapy for pancreatic cancer - clinical impact for preoperative therapy and peptide vaccine therapy]. PMID: 22421762 Ref: Imaging features of small ( PMID: 22495239 Ref: Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience. PMID: 22497945 Ref: Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer. PMID: 22723862 Ref: Update on prognostic and predictive biomarkers for pancreatic neuroendocrine tumors. PMID: 22797391 Ref: A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1. PMID: 22824559 Ref: BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer. PMID: 23047891 |
Ref: Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. PMID: 23345357 Ref: Net expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivo. PMID: 23469073 Ref: Novel agents in gastroenteropancreatic neuroendocrine tumors. PMID: 23474560 Ref: Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. PMID: 23803690 Ref: [A case of metastatic gastric cancer secondary to pancreatic neuroendocrine tumor fifteen years after distal pancreatectomy]. PMID: 23831659 Ref: Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. PMID: 24024929 Ref: Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies. PMID: 24182608 Ref: Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs). PMID: 24312683 Ref: Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence? PMID: 24616764 |
Ref: Detection of in vivo enzyme activity with CatalyCEST MRI. PMID: 23640714 Ref: Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options. PMID: 24014009 Ref: Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. PMID: 24142395 Ref: Systemic therapeutic strategies for GEP-NETS: what can we expect in the future? PMID: 24375390 Ref: Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. PMID: 24389729 Ref: nab-Paclitaxel Plus Gemcitabine Regimen for Pancreatic Cancer. PMID: 24421558 Ref: Neuroendocrine tumors of the pancreas: current concepts and controversies. PMID: 24430597 Ref: Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. PMID: 24440063 Ref: PCMdb: pancreatic cancer methylation database. PMID: 24569397 Ref: Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer. PMID: 24608575 Ref: The value of endoscopic ultrasound in a 47-year-old man with cystic lesions of the liver and pancreas. PMID: 24847197 Ref: Liver transplantation for metastatic neuroendocrine tumors. PMID: 25293619 Ref: The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors. PMID: 25301162 Ref: Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential. PMID: 25372771 Ref: Surgical treatment and clinical outcome of nonfunctional pancreatic neuroendocrine tumors: a 14-year experience from one single center. PMID: 25396335 Ref: Long-term disease control of a pancreatic neuroendocrine tumor with lanreotide autogel((R)): a case report. PMID: 25408662 |
Ref: Neurotensin, a novel target of Wnt/beta-catenin pathway, promotes growth of neuroendocrine tumor cells. PMID: 25098665 Ref: Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors. PMID: 25433656 Ref: 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study. PMID: 25479696 Ref: Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer. PMID: 25527450 Ref: Paraganglioma and pancreatic neuroendocrine tumor with rare metastatic sites detected on 68Ga-DOTATATE PET/CT imaging. PMID: 25546216 Ref: Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells. PMID: 25564970 Ref: MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'etude des Tumeurs Endocrines. PMID: 25594862 Ref: Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization. PMID: 25655623 Ref: Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer. PMID: 25688740 Ref: Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs. PMID: 25689143 Ref: SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. PMID: 25755250 Ref: Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor. PMID: 25791399 Ref: Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations. PMID: 25887286 Ref: Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT. PMID: 25916385 Ref: The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract. PMID: 26032155 Ref: NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study. PMID: 26181854 Ref: A nonfunctional neuroendocrine tumor of the pancreas - a case report. PMID: 26193221 Ref: Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors. PMID: 26313798 Ref: Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients. PMID: 26401467 Ref: [A Case of Von Hippel-Lindau Disease with Nonfunctioning Pancreatic Neuroendocrine Tumors Treated by Duodenum-Preserving Resection of the Head of the Pancreas and Spleen-Preserving Resection of the Tail of the Pancreas]. PMID: 26489587 Ref: [Two Cases of Pancreatic Neuroendocrine Tumor with Liver Metastases Successfully Treated with Multidisciplinary Therapy including Multiple Surgical Resections]. PMID: 26805376 |
Ref: Geographic disparities in pancreatic cancer survival in a southeastern safety-net academic medical center. PMID: 25989096 Ref: Adjuvant therapy for pancreas cancer in an era of value based cancer care. PMID: 26620819 Ref: Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review. PMID: 26643525 Ref: Financial Impact of Postoperative Complication Following Hepato-Pancreatico-Biliary Surgery for Cancer. PMID: 26714947 Ref: AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas. PMID: 26884209 Ref: Synchronous neuroendocrine tumors in both the pancreas and ileum: A case report. PMID: 27046104 Ref: Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature. PMID: 27053503 Ref: Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models. PMID: 27127884 Ref: A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. PMID: 27259015 Ref: Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis. PMID: 27414404 Ref: Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution. PMID: 27428224 Ref: [EARLY COMPLICATIONS IN PATIENTS, OPERATED FOR NEUROENDOCRINE TUMORS OF PANCREATIC GLAND]. PMID: 27434949 Ref: Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours. PMID: 27498883 Ref: Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. PMID: 27511850 Ref: Pre-operative Diagnosis of Pancreatic Neuroendocrine Tumors with Endoscopic Ultrasonography and Computed Tomography in a Large Series. PMID: 27689195 Ref: Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis. PMID: 27784972 Ref: Imaging of neuroendocrine tumors of the pancreas. PMID: 27876341 Ref: [Liver Metastases from Pancreatic Neuroendocrine Tumor(P-NET)Treated with Surgery and Chemotherapy]. PMID: 28133088 |
Ref: Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies. PMID: 27273754 Ref: Translational research in neuroendocrine tumors: pitfalls and opportunities. PMID: 27641330 Ref: Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. PMID: 27906872 Ref: Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor. PMID: 27942928 Ref: Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future. PMID: 28098761 Ref: The Value of Survival Gains in Pancreatic Cancer from Novel Treatment Regimens. PMID: 28125374 Ref: Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. PMID: 28238592 Ref: Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis. PMID: 28245569 Ref: Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. PMID: 28440551 Ref: Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study. PMID: 28455360 Ref: Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors. PMID: 28504695 Ref: Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China. PMID: 28521422 Ref: Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. PMID: 28558772 Ref: Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors. PMID: 28591817 Ref: Focus on an unusual rise in pancreatic cancer incidence in France. PMID: 28605500 Ref: Treatment of a mixed acinar-endocrine carcinoma with uptake on (68)Gallium-DOTATOC positron emission tomography-computed tomography: A case report. PMID: 28693204 Ref: The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna. PMID: 28761758 Ref: Major postoperative complications after pancreatic resection for P-NETS are not associated to earlier recurrence. PMID: 28821361 Ref: Germline Testing for Individuals With Pancreatic Cancer: The Benefits and Challenges to Casting a Wider Net. PMID: 28834438 Ref: Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells. PMID: 28885916 Ref: Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors. PMID: 28984786 Ref: AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis. PMID: 29079172 Ref: Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome. PMID: 29184699 Ref: Cost-effectiveness of laparoscopic versus open distal pancreatectomy for pancreatic cancer. PMID: 29272281 Ref: [Laparoscopic Pancreatectomy for Pancreatic Neuroendocrine Tumor - A Single Institution Experience]. PMID: 29394684 |
Ref: Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study. PMID: 28567607 Ref: Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. PMID: 28849340 Ref: Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals. PMID: 28849353 Ref: Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification. PMID: 29307515 Ref: Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer. PMID: 29382042 Ref: Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors. PMID: 29401168 Ref: Two-stage resection of a bilateral pheochromocytoma and pancreatic neuroendocrine tumor in a patient with von Hippel-Lindau disease: A case report. PMID: 29501019 Ref: Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression. PMID: 29521944 Ref: Force Spectroscopy on a Cell Drum: AFM Measurements on the Basolateral Side of Cells via Inverted Cell Cultures. PMID: 29595251 Ref: Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms. PMID: 29602973 Ref: Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential. PMID: 29629846 Ref: A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type of "High"-grade Well-Differentiated Neuroendocrine Neoplasm. PMID: 29675587 Ref: Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head. PMID: 29805684 Ref: Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances. PMID: 29912000 Ref: A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. PMID: 29915428 Ref: Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps. PMID: 29929491 Ref: T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. PMID: 29997287 Ref: The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. PMID: 30098710 Ref: COMPETITIVE TESTING THE WHO 2010 VS THE WHO 2017 GRADING OF PANCREAS NEUROENDOCRINE NEOPLASIA: DATA FROM A LARGE INTERNATIONAL COHORT STUDY. PMID: 30300897 Ref: [Neuroendocrine Neoplasia within the German NET Registry]. PMID: 30304748 |